Laidlaw Wealth Management LLC Axsome Therapeutics, Inc. Transaction History

Laidlaw Wealth Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$55.91 - $81.44 $138,544 - $201,808	-2,478 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$66.31 - $86.52 $164,316 - $214,396	2,478 New	2,478 $202,000
Q3 2020 Nov 16, 2020	SELL	$68.34 - $85.84 $256,138 - $321,728	-3,748 Closed	0 $0
Q2 2020 Aug 19, 2020	SELL	$49.87 - $98.69 $76.7 Million - $152 Million	-1,538,177 Reduced 99.76%	3,748 $308,000
Q2 2020 Aug 13, 2020	BUY	$49.87 - $98.69 $76.9 Million - $152 Million	1,541,925 New	1,541,925 $20,000
Q1 2020 May 15, 2020	SELL	$41.2 - $101.31 $100,322 - $246,689	-2,435 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$16.71 - $106.24 $40,688 - $258,694	2,435 New	2,435 $252,000

352

36.3M

1.77M

1.16M

Ticker AXSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,878,000
Market Cap $5.41B
Description
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...

Get notified when there are updates to the investment portfolio of Laidlaw Wealth Management LLC, based on Form 13F filings with the SEC.

Stay updated on Laidlaw Wealth Management LLC with notifications on news.